Buenos Aires, Argentina (UroToday.com) Sia Daneshmand, Professor at the University of Southern California, discussed use of frailty as a predictor of complications among elderly patients undergoing radical cystectomy.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Analyzing patients retrospectively (prospectively measured) using grip strength, walking speed, physical activity, shrinking and exhaustion. Comorbidities were assessed via standardized instruments. Shrinking was associated with a greater 30-day complication rate with a similar trend in patients frail grip strength. On multivariate analysis frail grip strength was associated with increased number of complications after controlling for pathologic stage and albumin. These results suggest a cost-effective alternative assessing frailty as well as interventions in these patients needed to decrease complications. At our institution, we use sarcopenia as measured by CT imaging as an assessment of frailty and decreased muscle mass index in order to identify patients who may benefit from aggressive perioperative nutrition counseling and supplementation.
World Urological Oncology Federation Symposium at the SIU Congress 2016 - October 20 - 23, 2016 – Buenos Aires, Argentina
Written By: Stephen B. Williams, M.D., Assistant Professor in Urology, The University of Texas Medical Branch, Galveston, TX. and Ashish Kamat, M.D. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.